Logo

Affy, Monsanto to Co-Develop Arabidopsis Array

Mar 26, 2002

NEW YORK, March 26 - Affymetrix and Monsanto on Tuesday said they plan to co-develop a single microarray that represents the Arabidopsis genome.

Monsanto said it will use this new array as part of its high-throughput discovery program.

 

The ag-bio giant also has licensed Affy's GeneChip technology to study plant development and disease.
 
Financial details of the agreement were not disclosed.

Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.